ITMCTR2200006718Not yet recruitingPhase 4
A prospective, single-center, randomized, open-label, parallel-controlled clinical study on the efficacy and safety of Shenfu Injection in the treatment of septic shock (Syndrome of Yang-Qi collapse)
Dongfang Hospital Beijing University of Chinese medicine0 sitesStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Ages
- 18 to — (—)
- Sex
- All
Inclusion Criteria
- •(1) Conforming to the diagnostic criteria of septic shock;
- •(2) Age >= 18 years;
- •(3) 4.5 mmol/L <= arterial blood lactic acid <= 7.0 mmol/L;
- •(4) Accord with the diagnostic criteria of yang qi collapse syndrome;
- •(5) GCS=15 points;
- •(6) Sign the informed consent form voluntarily.
Exclusion Criteria
- •(1) Poor prognosis (estimated survival time<24 hours);
- •(2) After cardiopulmonary resuscitation;
- •(3) Pregnant or lactating women;
- •(4) Participated in another clinical trial in the last three months;
- •(5) Blood purification is required during observation;
- •(6) People who are allergic to ginseng and aconite injection or contain red ginseng and aconite.
Investigators
Similar Trials
Completed
Not Applicable
A single-center, prospective, randomized, open-label, clinical trial of ceramide 2-containing hydrocolloid dressings versus polyurethane film dressings for pressure ulcer prevention in high-risk surgical patientsPressure ulcerJPRN-UMIN000019420Pressure Ulcer Committee of Tokyo Medical University Ibaraki Medical Canter128
Not yet recruiting
Not Applicable
Aggressive versus conservative endoscopic therapy for gastric varicesCTRI/2022/02/040188Surat Institute of Digestive Sciences
Recruiting
Unknown
Evaluation of genital skin cleaning technique in stroke patients: A comparative studyJPRN-UMIN000048846Fujita health university26
Active, not recruiting
Phase 1
Study to evaluate the efficacy and safety of Nicotinamide DS compared to Ciclopirox olamine at 1% cream in seborrheic dermatitis.Patients affected by seborrheic dermatitis.MedDRA version: 21.1Level: PTClassification code 10039793Term: Seborrhoeic dermatitisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2020-000720-19-ITIDI FARMACEUTICI SR102
Recruiting
Not Applicable
Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter pylori in KoreaCertain infectious and parasitic diseasesKCT0001176Seoul National University Bundang Hospital390